Gossamer Bio, Inc. - Common Stock — 貸借対照表 (NASDAQ:GOSS) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 539.43 M343.66 M272.45 M311.92 M315.29 M172.25 M 負債合計 218.75 M222.19 M260.37 M249.15 M285.8 M295.01 M 純資産合計 320.68 M121.46 M12.08 M62.77 M29.49 M-122.76 M 負債および純資産合計 539.43 M343.66 M272.45 M311.92 M315.29 M172.25 M 有利子負債合計 28.74 M29.08 M11.99 M814 K0— 純負債 28.74 M29.08 M11.99 M814 K0—

ニュース

Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates

Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Misses Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates

Bracing for Stagflation? These 2 Stocks Offer Mouth-Watering Upside - TipRanks.com

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - BrainsWay (NASDAQ:BWAY), Definitive Healthcare (NASDAQ:DH)

Alibaba Earnings, Jobs Data

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates